Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects

Molecular Imaging and Biology

Volumn 15, Issue 4, 2013, Pages 384-390

  Ahmad, Rawaha ^a   Koole, Michel ^a   Evens, Nele ^a   Serdons, Kim ^a   Verbruggen, Alfons ^a   Bormans, Guy ^a   Van Laere, Koen ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

11C NE40; Biodistribution; CB2R; Dosimetry; Positron emission tomography

Indexed keywords

NE 40 C 11; TRACER; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AGING; ARTICLE; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG UPTAKE; HEPATOBILIARY SYSTEM; HUMAN; HUMAN EXPERIMENT; LIVER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; SMALL INTESTINE; SPLEEN; WHOLE BODY PET;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEALTH; HEALTHY VOLUNTEERS; HUMANS; LIGANDS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; QUINOLINES; RADIOMETRY; RECEPTOR, CANNABINOID, CB2; TIME FACTORS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84880331685     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0626-y     Document Type: Article

References (37)

1. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
2. Felder CC, Joyce KE, Briley EM et al (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450
3. Lynn AB, Herkenham M (1994) Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268:1612-1623
4. Prestifilippo JP, Fernandez-Solari J, de la Cal C et al (2006) Inhibition of salivary secretion by activation of cannabinoid receptors. Exp Biol Med (Maywood) 231:1421-1429
5. Cavuoto P, McAinch AJ, Hatzinikolas G, Janovska A, Game P, Wittert GA (2007) The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochem Biophys Res Commun 364:105-110
6. Bermudez-Silva FJ, Suarez J, Baixeras E et al (2008) Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 51:476-487
7. El-Talatini MR, Taylor AH, Elson JC, Brown L, Davidson AC, Konje JC (2009) Localisation and function of the endocannabinoid system in the human ovary. PLoS One 4:e4579
8. Liu QR, Pan CH, Hishimoto A et al (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav 8:519-530
9. Onaivi ES (2006) Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 54:231-246
10. Van Sickle MD, Duncan M, Kingsley PJ et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329-332
11. Ehrhart J, Obregon D, Mori T et al (2005) Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation 2:29
12. Curto-Reyes V, Llames S, Hidalgo A, Menendez L, Baamonde A (2010) Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain. Br J Pharmacol 160:561-573
13. Bisogno T, Di Marzo V (2008) The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses. Curr Pharm Des 14:2299-3305
14. Pazos MR, Sagredo O, Fernandez-Ruiz J (2008) The endocannabinoid system in Huntington's disease. Curr Pharm Des 14:2317-2325
15. Benito C, Nunez E, Tolon RM et al (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23:11136-11141
16. Palazuelos J, Aguado T, Pazos MR et al (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain 132:3152-3164
17. Price DA, Martinez AA, Seillier A et al (2009) WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur J Neurosci 29:2177-2186
18. Burns HD, Van Laere K, Sanabria-Bohorquez S et al (2007) [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci USA 104:9800-9805
19. Donohue SR, Varnas K, Jia Z, Gulyas B, Pike VW, Halldin C (2009) Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors. Bioorg Med Chem Lett 19:6209-6212
20. Horti AG, Van Laere K (2008) Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain. Curr Pharm Des 14:3363-3383
21. Horti AG, Gao Y, Ravert HT et al (2010) Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). Bioorg Med Chem 18:5202-5207
22. Evens N, Bosier B, Lavey BJ et al (2008) Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor. Nucl Med Biol 35:793-800
23. Gao M, Wang M, Miller KD, Hutchins GD, Zheng QH (2010) Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging. Bioorg Med Chem 18:2099-2106
24. Evens N, Muccioli GG, Houbrechts N et al (2009) Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging. Nucl Med Biol 36:455-465
25. Evens N, Vandeputte C, Coolen C et al (2012) Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer. Nucl Med Biol 39:389-399
26. Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347-364
27. Evens N, Vandeputte C, Muccioli GG et al (2011) Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging. Bioorg Med Chem 19:4499-4505
28. Lassmann M, Chiesa C, Flux G, Bardies M, Committee ED (2011) EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging 38:192-200
29. Van Laere K, Koole M, Sanabria Bohorquez SM et al (2008) Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects. J Nucl Med 49:439-445
30. Bolch WE, Eckerman KF, Sgouros G, Thomas SR (2009) MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry - standardization of nomenclature. J Nucl Med 50:477-484
31. ICoR Protection (1979) Limits for intakes of radionuclides by workers. Pergamon Press, New York
32. Cloutier RJ, Smith SA, Watson EE, Snyder WS, Warner GG (1973) Dose to the fetus from radionuclides in the bladder. Heal Phys 25:147-161
33. ICRP (1991) ICRP Publication 60: recommendations of the International Commission on Radiological Protection. Pergamon Press, Oxford
34. Maccarrone M, Battista N, Centonze D (2007) The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases. Prog Neurobiol 81:349-379
35. Raitio KH, Savinainen JR, Nevalainen T, Jarvinen T, Vepsalainen J (2006) Synthesis and in vitro evaluation of novel 2-oxo-1,2-dihydroquinoline CB2 receptor inverse agonists. Chem Biol Drug Des 68:334-340
36. Turkman N, Shavrin A, Paolillo V et al (2012) Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor. Nucl Med Biol 39:593-600
37. van der Aart J, Hallett WA, Rabiner EA, Passchier J, Comley RA (2012) Radiation dose estimates for carbon-11-labelled PET tracers. Nucl Med Biol 39:305-314